跳至主要内容
临床试验/NL-OMON23452
NL-OMON23452招募中不适用

ow-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: A randomized controlled trial of two doses.

Academic Medical Center0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age > 18 years;
  • 2. Pregnancy confirmed by urinary pregnancy test;

排除标准

  • 1. Previous VTE related to a major provoking risk factor (e.g. surgery, major trauma or plaster cast immobilisation in the 3 months prior to VTE) as the sole risk factor;
  • 2. Indication for treatment with therapeutic dose anticoagulant therapy (e.g. treatment of acute VTE; permanent use of therapeutic anticoagulants outside of pregnancy);

研究者

发起方
Academic Medical Center

相似试验